Company intelligence / Profile preview

Airofit

Copenhagen, Denmark

Ownership: Private
Development stage: Other

Overview

Airofit develops science-backed respiratory muscle training devices that improve lung capacity, respiratory muscle strength, and overall health. Their products are used by athletes, individuals with respiratory conditions, and general consumers seeking better breathing and stress management. Clinical results, including a study in cooperation with AMBU International, show significant improvements in athletic performance with regular respiratory training. The platform is integrated with a mobile app for guided exercises and data tracking.

Therapeutic areas: PulmonologyNeurologyOtherPsychiatry
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

AMBU International (clinical survey partner)

Beyond the preview

Go deeper on Airofit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Airofit.

Explore the full profile